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Bacterial contamination and biofilm formation are well
recognized in the setting of intermittent hemodialysis and
have led to the development of well-defined requirements for
water and dialysate purity. The standards are even more
stringent in the setting of intermittent hemodiafiltration
because of the need for systemic infusion of the replacement
fluid. Until lately, little attention had been paid to the
microbial integrity of the continuous renal replacement
therapies (CRRTs) used in critically ill patients. However,
recently published work has revealed evidence of widespread
microbial contamination of both bicarbonate-based dialysate
and replacement fluid circuits in CRRTs.
The electron micrographs, shown above, are of the internal
surface of a replacement fluid circuit tubing harvested at the
end of a 60-h continuous veno-venous hemofiltration
(CVVH) treatment. Industry-standard circuitry and replace-
ment fluid were used. Figure 1a is taken at low power (58
magnification) and illustrates the biofilm spreading across the
surface of the tubing. Figure 1b (8300) shows the biofilm
with adherent microbes. Despite using sensitive techniques,
the infusate, sampled at the end of treatment, did not reveal
levels of either endotoxin or colony-forming units that would
breach modern standards, although other circuits did.
The significance of these findings, with regard to the
source of contamination, the effect on the patient, and the
optimum circuit lifespan, fluid, or treatment modality
(dialysis vs hemofiltration), remains unclear, but they do
highlight the need for further work.
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Figure 1 |CVVH replacement tubing after 60-h treatment.
(a) Biofilm (low power) (b) biofilm and microbes (high power).
CVVH, continous veno-venous hemofiltration.
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